# Unifirst Corp: financial statements, quarterly

UNF · NYSE · CIK 717954 · [Industrials](/sectors/industrials.md) · fiscal year ends Aug 29

Pages: [Overview](/companies/unf.md) · [Financials](/companies/unf/financials.md) · [Filings](/companies/unf/filings.md) · [Insiders](/companies/unf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/unf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-08-26) | Q1 FY2024 (2023-11-25) | Q2 FY2024 (2024-02-24) | Q3 FY2024 (2024-05-25) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-03-01) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-30) | Q1 FY2026 (2025-11-29) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [572 d](/filings/0001193125-25-256222.md) | [594](/filings/0000950170-25-003833.md) | [591](/filings/0000950170-25-052817.md) | [603](/filings/0000950170-25-094853.md) | [640 d](/filings/0001193125-25-256222.md) | [605](/filings/0001193125-26-006587.md) | [602](/filings/0001193125-26-144908.md) | [611](/filings/0001628280-26-047621.md) | [614 d](/filings/0001193125-25-256222.md) | [621](/filings/0001193125-26-006587.md) | [623](/filings/0001193125-26-144908.md) | [634](/filings/0001628280-26-047621.md) |
| Cost of revenue | $m | [378 d](/filings/0001193125-25-256222.md) | [384](/filings/0000950170-25-003833.md) | [396](/filings/0000950170-25-052817.md) | [391](/filings/0000950170-25-094853.md) | [409 d](/filings/0001193125-25-256222.md) | [381](/filings/0001193125-26-006587.md) | [394](/filings/0001193125-26-144908.md) | [385](/filings/0001628280-26-047621.md) | [382 d](/filings/0001193125-25-256222.md) | [393](/filings/0001193125-26-006587.md) | [404](/filings/0001193125-26-144908.md) | [400](/filings/0001628280-26-047621.md) |
| Selling, general and administrative | $m | [125 d](/filings/0001193125-25-256222.md) | [123](/filings/0000950170-25-003833.md) | [131](/filings/0000950170-25-052817.md) | [129](/filings/0000950170-25-094853.md) | [139 d](/filings/0001193125-25-256222.md) | [134](/filings/0001193125-26-006587.md) | [142](/filings/0001193125-26-144908.md) | [143](/filings/0001628280-26-047621.md) | [147 d](/filings/0001193125-25-256222.md) | [148](/filings/0001193125-26-006587.md) | [157](/filings/0001193125-26-144908.md) | [176](/filings/0001628280-26-047621.md) |
| Operating income | $m | [36.1 d](/filings/0001193125-25-256222.md) | [53.1](/filings/0000950170-25-003833.md) | [27.9](/filings/0000950170-25-052817.md) | [48.5](/filings/0000950170-25-094853.md) | [54.0 d](/filings/0001193125-25-256222.md) | [55.5](/filings/0001193125-26-006587.md) | [31.2](/filings/0001193125-26-144908.md) | [48.2](/filings/0001628280-26-047621.md) | [49.6 d](/filings/0001193125-25-256222.md) | [45.3](/filings/0001193125-26-006587.md) | [26.0](/filings/0001193125-26-144908.md) | [23.0](/filings/0001628280-26-047621.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [2.2](/filings/0001193125-26-144908.md) | not reported | not reported | not reported | [1.6](/filings/0001193125-26-144908.md) | not reported |
| Income tax | $m | [8.9 d](/filings/0001193125-25-256222.md) | [12.9](/filings/0000950170-25-003833.md) | [7.3](/filings/0000950170-25-052817.md) | [11.3](/filings/0000950170-25-094853.md) | [12.4 d](/filings/0001193125-25-256222.md) | [14.8](/filings/0001193125-26-006587.md) | [8.2](/filings/0001193125-26-144908.md) | [13.7](/filings/0001628280-26-047621.md) | [10.4 d](/filings/0001193125-25-256222.md) | [12.6](/filings/0001193125-26-006587.md) | [6.9](/filings/0001193125-26-144908.md) | [4.5](/filings/0001628280-26-047621.md) |
| Net income | $m | [27.6 d](/filings/0001193125-25-256222.md) | [42.3](/filings/0000950170-25-094853.md) | [20.5](/filings/0000950170-25-094853.md) | [38.1](/filings/0000950170-25-094853.md) | [44.6 d](/filings/0001193125-25-256222.md) | [43.1](/filings/0001628280-26-047621.md) | [24.5](/filings/0001628280-26-047621.md) | [39.7](/filings/0001628280-26-047621.md) | [41.0 d](/filings/0001193125-25-256222.md) | [34.4](/filings/0001628280-26-047621.md) | [20.5](/filings/0001628280-26-047621.md) | [19.9](/filings/0001628280-26-047621.md) |
| Diluted EPS | $ per share | not reported | [2.26](/filings/0000950170-25-003833.md) | [1.09](/filings/0000950170-25-052817.md) | [2.03](/filings/0000950170-25-094853.md) | not reported | [2.31](/filings/0001193125-26-006587.md) | [1.31](/filings/0001193125-26-144908.md) | [2.13](/filings/0001628280-26-047621.md) | not reported | [1.89](/filings/0001193125-26-006587.md) | [1.13](/filings/0001193125-26-144908.md) | [1.09](/filings/0001628280-26-047621.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted

## Balance sheet

| Line item | Unit | FY2023 (2023-08-26) | Q1 FY2024 (2023-11-25) | Q2 FY2024 (2024-02-24) | Q3 FY2024 (2024-05-25) | FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-03-01) | Q3 FY2025 (2025-05-31) | FY2025 (2025-08-30) | Q1 FY2026 (2025-11-29) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [79.4](/filings/0000950170-24-127140.md) | [77.4](/filings/0000950170-24-001773.md) | [90.5](/filings/0000950170-24-041726.md) | [112](/filings/0000950170-24-081314.md) | [162](/filings/0001193125-25-256222.md) | [166](/filings/0000950170-25-003833.md) | [192](/filings/0000950170-25-052817.md) | [212](/filings/0000950170-25-094853.md) | [204](/filings/0001628280-26-047621.md) | [124](/filings/0001193125-26-006587.md) | [152](/filings/0001193125-26-144908.md) | [163](/filings/0001628280-26-047621.md) |
| Current assets | $m | [840](/filings/0000950170-24-127140.md) | [859](/filings/0000950170-24-001773.md) | [864](/filings/0000950170-24-041726.md) | [884](/filings/0000950170-24-081314.md) | [916](/filings/0001193125-25-256222.md) | [916](/filings/0000950170-25-003833.md) | [937](/filings/0000950170-25-052817.md) | [938](/filings/0000950170-25-094853.md) | [925](/filings/0001628280-26-047621.md) | [873](/filings/0001193125-26-006587.md) | [903](/filings/0001193125-26-144908.md) | [920](/filings/0001628280-26-047621.md) |
| Total assets | $m | [2,570](/filings/0000950170-24-127140.md) | [2,602](/filings/0000950170-24-001773.md) | [2,621](/filings/0000950170-24-041726.md) | [2,651](/filings/0000950170-24-081314.md) | [2,696](/filings/0001193125-25-256222.md) | [2,702](/filings/0000950170-25-003833.md) | [2,733](/filings/0000950170-25-052817.md) | [2,760](/filings/0000950170-25-094853.md) | [2,778](/filings/0001628280-26-047621.md) | [2,753](/filings/0001193125-26-006587.md) | [2,800](/filings/0001193125-26-144908.md) | [2,821](/filings/0001628280-26-047621.md) |
| Current liabilities | $m | [267](/filings/0000950170-24-127140.md) | [259](/filings/0000950170-24-001773.md) | [263](/filings/0000950170-24-041726.md) | [270](/filings/0000950170-24-081314.md) | [281](/filings/0001193125-25-256222.md) | [261](/filings/0000950170-25-003833.md) | [278](/filings/0000950170-25-052817.md) | [267](/filings/0000950170-25-094853.md) | [290](/filings/0001628280-26-047621.md) | [264](/filings/0001193125-26-006587.md) | [290](/filings/0001193125-26-144908.md) | [296](/filings/0001628280-26-047621.md) |
| Total liabilities | $m | [566](/filings/0000950170-24-127140.md) | [562](/filings/0000950170-24-001773.md) | [571](/filings/0000950170-24-041726.md) | [576](/filings/0000950170-24-081314.md) | [588](/filings/0001193125-25-256222.md) | [568](/filings/0000950170-25-003833.md) | [590](/filings/0000950170-25-052817.md) | [585](/filings/0000950170-25-094853.md) | [609](/filings/0001628280-26-047621.md) | [590](/filings/0001193125-26-006587.md) | [617](/filings/0001193125-26-144908.md) | [623](/filings/0001628280-26-047621.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,004](/filings/0001193125-25-256222.md) | [2,040](/filings/0000950170-25-094853.md) | [2,050](/filings/0000950170-25-094853.md) | [2,076](/filings/0000950170-25-094853.md) | [2,109](/filings/0001628280-26-047621.md) | [2,134](/filings/0001628280-26-047621.md) | [2,144](/filings/0001628280-26-047621.md) | [2,175](/filings/0001628280-26-047621.md) | [2,169](/filings/0001628280-26-047621.md) | [2,163](/filings/0001628280-26-047621.md) | [2,183](/filings/0001628280-26-047621.md) | [2,198](/filings/0001628280-26-047621.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-08-26) | Q1 FY2024 (2023-11-25) | Q2 FY2024 (2024-02-24) | Q3 FY2024 (2024-05-25) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-03-01) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-30) | Q1 FY2026 (2025-11-29) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [73.0 d](/filings/0001193125-25-256222.md) | [45.7](/filings/0000950170-25-003833.md) | [61.1 d](/filings/0000950170-25-052817.md) | [86.3 d](/filings/0000950170-25-094853.md) | [102 d](/filings/0001193125-25-256222.md) | [58.1](/filings/0001193125-26-006587.md) | [70.2 d](/filings/0001193125-26-144908.md) | [68.2 d](/filings/0001628280-26-047621.md) | [100 d](/filings/0001193125-25-256222.md) | [14.9](/filings/0001193125-26-006587.md) | [73.6 d](/filings/0001193125-26-144908.md) | [50.9 d](/filings/0001628280-26-047621.md) |
| Capital expenditure | $m | [47.9 d](/filings/0001193125-25-256222.md) | [39.1](/filings/0000950170-25-003833.md) | [33.9 d](/filings/0000950170-25-052817.md) | [49.0 d](/filings/0000950170-25-094853.md) | [38.5 d](/filings/0001193125-25-256222.md) | [33.6](/filings/0001193125-26-006587.md) | [32.5 d](/filings/0001193125-26-144908.md) | [43.7 d](/filings/0001628280-26-047621.md) | [44.5 d](/filings/0001193125-25-256222.md) | [38.9](/filings/0001193125-26-006587.md) | [38.4 d](/filings/0001193125-26-144908.md) | [29.7 d](/filings/0001628280-26-047621.md) |
| Dividends paid | $m | [5.6 d](/filings/0001193125-25-256222.md) | [5.6](/filings/0000950170-25-003833.md) | [5.9 d](/filings/0000950170-25-052817.md) | [5.9 d](/filings/0000950170-25-094853.md) | [5.9 d](/filings/0001193125-25-256222.md) | [5.9](/filings/0001193125-26-006587.md) | [6.3 d](/filings/0001193125-26-144908.md) | [6.2 d](/filings/0001628280-26-047621.md) | [6.2 d](/filings/0001193125-25-256222.md) | [6.1](/filings/0001193125-26-006587.md) | [6.3 d](/filings/0001193125-26-144908.md) | [6.3 d](/filings/0001628280-26-047621.md) |
| Share repurchases | $m | [0.0 d](/filings/0001193125-25-256222.md) | [0.3](/filings/0000950170-25-003833.md) | [7.9 d](/filings/0000950170-25-052817.md) | [7.8 d](/filings/0000950170-25-094853.md) | [7.8 d](/filings/0001193125-25-256222.md) | [6.4](/filings/0001193125-26-006587.md) | [6.2 d](/filings/0001193125-26-144908.md) | [13.1 d](/filings/0001628280-26-047621.md) | [45.3 d](/filings/0001193125-25-256222.md) | [32.7](/filings/0001193125-26-006587.md) | [0.0 d](/filings/0001193125-26-144908.md) | [0.0 d](/filings/0001628280-26-047621.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-11-26) | Q2 FY2023 (2023-02-25) | Q3 FY2023 (2023-05-27) | Q1 FY2024 (2023-11-25) | Q2 FY2024 (2024-02-24) | Q3 FY2024 (2024-05-25) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-03-01) | Q3 FY2025 (2025-05-31) | Q1 FY2026 (2025-11-29) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.8](/filings/0000950170-24-001773.md) | [18.8](/filings/0000950170-24-041726.md) | [18.7](/filings/0000950170-24-081314.md) | [18.8](/filings/0000950170-25-003833.md) | [18.8](/filings/0000950170-25-052817.md) | [18.7](/filings/0000950170-25-094853.md) | [18.7](/filings/0001193125-26-006587.md) | [18.6](/filings/0001193125-26-144908.md) | [18.6](/filings/0001628280-26-047621.md) | [18.2](/filings/0001193125-26-006587.md) | [18.1](/filings/0001193125-26-144908.md) | [18.2](/filings/0001628280-26-047621.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,868,648 at 2011-07-01, from the cover of the [10-Q filed 2011-07-07](/filings/0001284084-11-000034.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.